Vision Biotechnology Global Manufacturing Network
Infinity IVD delivered facility-development, production-infrastructure, equipment-integration and manufacturing-capability establishment work across Vision Biotechnology’s disclosed international manufacturing network.
What is publicly disclosed.
Infinity IVD delivered facility-development, production-infrastructure, equipment-integration and manufacturing-capability establishment work across Vision Biotechnology’s disclosed international manufacturing network.
The project is classified as International diagnostic-manufacturing network. Its public status is Completed, and the published location is Türkiye · United States · Germany · Romania · Azerbaijan · Nigeria. Where the disclosed area is available, it is stated as Published technical detail varies by country; this value is not converted into a cleanroom, operating or ownership claim.
Scope is separated by work package.
- Facility and production-infrastructure planning
- Equipment integration and production implementation
- Quality-system support and controlled technology transfer
- Country-specific diagnostic-platform localisation
Each item describes the disclosed engagement boundary. It does not imply services outside the listed scope or transfer responsibility from the client, operator, technology owner or competent authority.
Evidence follows the Seven-Gate Framework.
Reference evidence is assessed against investment definition, concept design, engineering, procurement and technology integration, quality readiness, commissioning and operational handover. The applicable gates depend on the contracted work packages. A design-only engagement is not presented as construction; equipment supply is not presented as complete EPC.
Review the Seven-Gate Framework ↗What this page does not claim.
The network entry does not imply that every country manufactures every Vision product family. Country-specific capability is stated only where confirmed.
Certification, accreditation, product registration and market authorisation remain subject to independent competent authorities and the accountable legal entity. Commercial values, restricted drawings, capacities and client documentation are released only where authorised or during qualified due diligence under NDA.
Connect the reference to an investable project scope.
The reference demonstrates a disclosed technical engagement, not a generic promise of identical cost, capacity or schedule elsewhere. A new programme must be sized for destination-market demand, utilities, workforce, regulatory pathway, site conditions and intended operating model.